We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$339B
AUM Growth
+$32.7B
Cap. Flow
+$7.03B
Cap. Flow %
2.08%
Top 10 Hldgs %
18.14%
Holding
3,647
New
148
Increased
2,572
Reduced
501
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 21.96%
2 Financials 12.71%
3 Healthcare 11.98%
4 Consumer Discretionary 10.85%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMTX
3301
DELISTED
BM Technologies, Inc.
BMTX
$270K ﹤0.01%
29,782
-13,582
-31% -$135K
EVGO icon
3302
EVgo
EVGO
$223M
$269K ﹤0.01%
27,046
FMS icon
3303
Fresenius Medical Care
FMS
$13.8B
$268K ﹤0.01%
8,246
-626
-7% -$20.6K
AOMR
3304
Angel Oak Mortgage REIT
AOMR
$220M
$267K ﹤0.01%
16,299
CVRX icon
3305
CVRx
CVRX
$137M
$267K ﹤0.01%
21,796
+1,928
+10% +$28K
TNGX icon
3306
Tango Therapeutics
TNGX
$4.43B
$266K ﹤0.01%
24,311
AVTX icon
3307
Avalo Therapeutics
AVTX
$965M
$265K ﹤0.01%
54
+8
+17% +$48K
SLDB icon
3308
Solid Biosciences
SLDB
$794M
$265K ﹤0.01%
10,062
EDR
3309
DELISTED
Endeavor Group Holdings, Inc.
EDR
$264K ﹤0.01%
7,563
+56
+0.7% +$1.58K
CYT
3310
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$259K ﹤0.01%
22,727
+2,158
+10% +$32.9K
XLO icon
3311
Xilio Therapeutics
XLO
$59.9M
$258K ﹤0.01%
+1,150
New +$274K
TDUP icon
3312
ThredUp
TDUP
$746M
$257K ﹤0.01%
+20,108
New +$366K
TRVN
3313
DELISTED
Trevena, Inc.
TRVN
$257K ﹤0.01%
705
JOAN
3314
DELISTED
JOANN, Inc. Common Stock
JOAN
$257K ﹤0.01%
24,715
+105
+0.4% +$1.1K
RXST icon
3315
RxSight
RXST
$249M
$255K ﹤0.01%
22,635
+2,457
+12% +$29.5K
FTH
3316
Faeth Therapeutics
FTH
$702M
$255K ﹤0.01%
2,193
-136
-6% -$20.3K
PYXS icon
3317
Pyxis Oncology
PYXS
$168M
$254K ﹤0.01%
+23,094
New +$264K
QSI icon
3318
Quantum-Si Incorporated
QSI
$155M
$252K ﹤0.01%
32,018
WLFC icon
3319
Willis Lease Finance
WLFC
$1.7B
$252K ﹤0.01%
20,022
+2,598
+15% +$33.1K
INDI icon
3320
indie Semiconductor
INDI
$682M
$251K ﹤0.01%
20,931
VCTR icon
3321
Victory Capital Holdings
VCTR
$6.19B
$251K ﹤0.01%
6,857
CSSE
3322
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$251K ﹤0.01%
18,070
BRDG
3323
DELISTED
Bridge Investment Group
BRDG
$249K ﹤0.01%
+9,940
New +$199K
INZY
3324
DELISTED
Inozyme Pharma
INZY
$249K ﹤0.01%
36,427
TGLS icon
3325
Tecnoglass Holdings Inc.
TGLS
$1.93B
$249K ﹤0.01%
+9,485
New +$266K

Similar funds

Charles Schwab's Q4 2021 Portfolio in Review

As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
  • Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
  • Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
  • Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
  • Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
  • Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
  • Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.

Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.